Intelligent Neurological Function Evaluation System

Publication ID: 24-11857349_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Neurological Function Evaluation System,” Published Technical Disclosure No. 24-11857349_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857349_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,349.

Summary of the Inventive Concept

An integrated system that combines AI, IoT, blockchain, and new materials to evaluate and improve neurological and cognitive function, enhancing patient outcomes and experiences.

Background and Problem Solved

The original patent addressed the need for a performance test to evaluate neurological function. However, it lacked the capacity to integrate with emerging technologies, limiting its potential. The new inventive concept solves this problem by synergistically combining the original apparatus with AI, IoT, blockchain, and new materials to create a more comprehensive and powerful system.

Detailed Description of the Inventive Concept

The system comprises an apparatus integrated with an AI-powered analytics module, which provides real-time assessment of neurological and cognitive function. The apparatus is further connected to an IoT-based sensor network, collecting and analyzing environmental and physiological data. A blockchain-based data storage system securely stores and manages patient data. The system also features a moveable platform with an integrated AI-powered chatbot, assisting patients during testing, and a new material-based contact surface enhancing the user experience. Additionally, the system includes a machine learning-based predictive model to identify potential neurological disorders and a blockchain-based rewards platform to incentivize patients to undergo regular testing.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, blockchain, and new materials with the original apparatus, creating a synergistic system that provides real-time assessment, personalized reports, and enhanced user experience. This integration is novel and non-obvious compared to the original patent.

Alternative Embodiments and Variations

Alternative embodiments could include integrating the system with virtual or augmented reality platforms, using different types of sensors or data analytics modules, or incorporating additional AI-powered features such as personalized coaching or predictive modeling. Variations could also include adapting the system for use in different settings, such as clinics, hospitals, or remote monitoring environments.

Potential Commercial Applications and Market

The Intelligent Neurological Function Evaluation System has significant commercial potential in the healthcare and medical technology industries, particularly in the areas of neurological disorder diagnosis, treatment, and management. The system could be marketed to hospitals, clinics, and research institutions, with potential for expansion into remote patient monitoring and personalized health services.

CPC Classifications

SectionClassGroup
A A61 A61B5/7271
A A61 A61B3/032
A A61 A61B5/11
A A61 A61B5/112
A A61 A61B5/1124
A A61 A61B5/1125
A A61 A61B5/16
A A61 A61B5/165
A A61 A61B5/225
A A61 A61B5/4023
A A61 A61B5/4076
A A61 A61B5/4082
A A61 A61B5/4088
A A61 A61B5/162
A A61 A61B2560/04
A A61 A61B2562/0219
G G06 G06F2203/04809

Field of Art

Medical diagnostic technologies, specifically neurological and cognitive function assessment systems, involving computing devices, sensor networks, and diagnostic interfaces

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or computer scientist with expertise in medical device design, neurological testing technologies, and digital health platforms, possessing knowledge of sensor integration, data analytics, and user interface design

Obviousness Rationale

A person having ordinary skill would recognize that integrating AI, IoT, and blockchain technologies into the existing neurological testing apparatus represents a predictable extension of known medical diagnostic approaches. The source patent's foundational testing apparatus provides a clear technological framework that a skilled practitioner would naturally augment with contemporary digital health technologies. The proposed variations represent incremental improvements using standard engineering techniques and readily available technological components.

Obvious Combinations & Variations

Source Patent Element
Test fixture overlaying a computing device's display screen with receptacle-based contact testing
PTD Variation
Adding AI-powered analytics module for real-time neurological function assessment
Obviousness Reasoning
Integrating computational analysis into existing diagnostic interfaces is a known technique in medical technology, representing a predictable application of machine learning to existing testing methodologies
Source Patent Element
Computing device with touch screen interface for neurological testing
PTD Variation
IoT-based sensor network for collecting environmental and physiological data during testing
Obviousness Reasoning
Expanding data collection capabilities through sensor integration is a standard design choice in medical diagnostic technologies, offering enhanced diagnostic insights through additional contextual information
Source Patent Element
Base fixture configured for overlaying computing device display
PTD Variation
Blockchain-based secure data storage and management system for patient testing records
Obviousness Reasoning
Implementing secure, distributed data management is a predictable technological evolution for medical diagnostic systems, addressing growing requirements for patient data protection and interoperability
Source Patent Element
Test apparatus designed for neurological function evaluation
PTD Variation
AI-powered chatbot integrated into testing platform to assist patients during assessment
Obviousness Reasoning
Incorporating interactive guidance technologies into medical testing interfaces represents a logical extension of user experience design principles, using well-established conversational AI techniques
Source Patent Element
Computing device-based neurological testing method
PTD Variation
Machine learning predictive model for identifying potential neurological disorders
Obviousness Reasoning
Applying advanced statistical analysis and pattern recognition to diagnostic data is a standard approach in medical technology, representing an obvious enhancement to existing testing methodologies
35 U.S.C. § 103 Summary: Based on US Patent 11857349's foundational teachings of a neurological testing apparatus, the present disclosure demonstrates that a person having ordinary skill in medical diagnostic technologies would find the integration of AI, IoT, blockchain, and advanced analytics technologies to be an obvious and predictable extension of existing neurological testing methodologies, thereby rendering potential derivative claims obvious and non-patentable.

Original Patent Information

Patent NumberUS 11,857,349
TitleApparatus and related method to facilitate test via a computing device
Assignee(s)THE CLEVELAND CLINIC FOUNDATION, BIOGEN MA INC.